These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 2472850

  • 1. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
    Kleven MS, Woolverton WL, Seiden LS.
    Brain Res; 1989 May 29; 488(1-2):121-5. PubMed ID: 2472850
    [Abstract] [Full Text] [Related]

  • 2. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G, Yeh SY, De Souza EB.
    Pharmacol Biochem Behav; 1988 Feb 29; 29(2):269-74. PubMed ID: 2452449
    [Abstract] [Full Text] [Related]

  • 3. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR.
    Toxicol Appl Pharmacol; 1988 Jul 29; 94(3):448-57. PubMed ID: 2456631
    [Abstract] [Full Text] [Related]

  • 4. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB.
    J Pharmacol Exp Ther; 1989 Jun 29; 249(3):713-20. PubMed ID: 2471824
    [Abstract] [Full Text] [Related]

  • 5. (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates.
    Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Langston JW.
    JAMA; 1988 Jul 01; 260(1):51-5. PubMed ID: 2454332
    [Abstract] [Full Text] [Related]

  • 6. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 01; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

  • 7. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA, Martello AL, Katz JL, Martello MB.
    J Pharmacol Exp Ther; 1992 May 01; 261(2):616-22. PubMed ID: 1374470
    [Abstract] [Full Text] [Related]

  • 8. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration.
    Ricaurte GA, DeLanney LE, Irwin I, Langston JW.
    Brain Res; 1988 Apr 12; 446(1):165-8. PubMed ID: 2897228
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
    Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS.
    J Pharmacol Exp Ther; 1987 Apr 12; 241(1):338-45. PubMed ID: 2883295
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI, Green AR.
    Br J Pharmacol; 1994 Jan 12; 111(1):131-6. PubMed ID: 7516800
    [Abstract] [Full Text] [Related]

  • 13. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI, Murray TK, Green AR.
    Br J Pharmacol; 1993 Mar 12; 108(3):583-9. PubMed ID: 7682129
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
    Steele TD, Katz JL, Ricaurte GA.
    Brain Res; 1992 Sep 04; 589(2):349-52. PubMed ID: 1382813
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA).
    Paris JM, Cunningham KA.
    Brain Res Bull; 1992 Jan 04; 28(1):115-9. PubMed ID: 1347247
    [Abstract] [Full Text] [Related]

  • 18. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
    Johnson MP, Huang XM, Nichols DE.
    Pharmacol Biochem Behav; 1991 Dec 04; 40(4):915-22. PubMed ID: 1726189
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue.
    Schmidt CJ, Wu L, Lovenberg W.
    Eur J Pharmacol; 1986 May 13; 124(1-2):175-8. PubMed ID: 2424776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.